AlphAIAlphAI — Financial news for AI agents
fool.comSEP 162 min read$CME

CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?

CME Group (CME) and Morningstar (MORN) are compared as financial infrastructure stocks. CME reported $6.5B revenue, $4B net income, and a 62% net margin in 2025. Morningstar reported $2.4B revenue, $374.2M net income, and a 15.3% net margin. Both face competitive and operational risks.

Original reporting
fool.com
Published Sep 16, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026? — source image
Source · fool.com
Decision brief

The 30-second read

$CMENeutralLow
01

Why it matters

The article offers no new information beyond what was already disclosed in the companies' annual reports, limiting trading relevance.

02

Market read

A recap of existing financial data; low immediate trading relevance.

03

What to watch

Potential future regulatory changes for CME and AI‑risk for Morningstar are mentioned but not quantified.

Relevance 4/10Novelty 2/10

Background

The piece is a comparative analysis of CME Group and Morningstar using their FY2025 financial results and valuation metrics.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

Article recaps CME Group's FY2025 revenue, net income and free cash flow figures from its annual report.

Expected impact

Limited impact; price likely unchanged.

Evidence & confidence

Numbers are already public; article provides no fresh information.

$MORNNeutralHigh confidence
Context

Article summarizes Morningstar's FY2025 revenue, net income and free cash flow from its annual filing.

Expected impact

Limited impact; price likely unchanged.

Evidence & confidence

Data were disclosed earlier; article adds no new insight.

Market effects

Sector

Provides a side‑by‑side view of financial‑services infrastructure firms, but no new sector shift.

Regional

U.S. financial‑services sector only; no broader regional effect.

Global

Limited; comparison of two U.S. listed companies.

Counterpoint

What could challenge this read

Without fresh data, any trade based on this comparison is speculative.

Key entities

  • company
    CME Group

    Global derivatives exchange operator.

  • company
    Morningstar

    Investment research and data provider.

Read at source← All news

Related articles

OCT 11
$CMEMed

FanDuel Gets FCM License, Raising Questions Over CME Role in Predicts

FanDuel has received a futures commission merchant (FCM) license from the National Futures Association, allowing it more control over its U.S. prediction market business. The approval raises questions about its partnership with CME Group, which holds a 51% stake in FanDuel Predicts. CME's CEO previously stated that such a license could conflict with their agreement. FanDuel's new license does not permit it to operate its own exchange, but it may seek further approvals in the future.

bonus.com2 min
OCT 8
$CMEMed

Baseball may get its first stats-based trading contracts Oct. 12, pending regulatory review.

CME Group plans to launch baseball futures on October 12, 2026, pending regulatory approval. The contracts will track CME FutureSports Performance Indexes, based on official league data of 30 professional baseball teams. Standard contracts will be valued at 10x the indexes, while micro contracts will be 1/10 their value. Trading will begin with the 2026 Postseason and the four clubs in the League Championship Series.

stocktitan.net2 min
OCT 7
$MORNHigh

Morningstar (MORN) Stock Is Up, What You Need To Know

Morningstar (MORN) shares rose 4.4% after launching Morningstar Direct AI, a software platform for investment professionals. The stock later settled at $201.46, up 2.9%. The AI tools integrate with Claude, Microsoft Copilot, and ChatGPT. Morningstar's stock is down 4.3% YTD and 11.7% below its 52-week high.

financialcontent.com2 min